109 filings
Page 5 of 6
8-K
cb8kc9
5 Aug 16
Entry into a Material Definitive Agreement
12:00am
8-K
ohagsqkx rrtxp7b4
3 Aug 16
Inotek Pharmaceuticals Announces Proposed Public Offering of $50
12:00am
8-K
gjdegvvp
1 Aug 16
Results of Operations and Financial Condition
12:00am
8-K
dmky42lwcumzipzh
22 Jul 16
Inotek Pharmaceuticals Expands Intellectual Property Portfolio with Combination Patent
12:00am
8-K
h8wz ev3va65
14 Jul 16
Other Events
12:00am
8-K
394k08ogtt
27 Jun 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
l96e8 4mp86d4uwwe1
11 May 16
Inotek Pharmaceuticals Corporation Reports First Quarter 2016 Financial Results and Operational Highlights
12:00am
8-K
11dd17acgxje1a
4 Apr 16
Inotek Pharmaceuticals Announces Changes to Board of Directors
12:00am
8-K
z7yx 23fuf6lwj9usm
25 Mar 16
Other Events
12:00am
8-K
fxmcohad6
23 Mar 16
Inotek Pharmaceuticals Corporation Reports Fiscal Year 2015 Financial Results and Operational Highlights
12:00am
8-K
p4lrlg5mn2iz
11 Mar 16
Inotek Pharmaceuticals Strengthens Patent Estate for Lead Product CandidateTrabodenoson
12:00am
8-K
1zx5v5
26 Feb 16
Entry into a Material Definitive Agreement
12:00am
8-K
b6ujcc98y4i03vwzp
12 Jan 16
Inotek Pharmaceuticals Appoints Carsten Boess to Board of Directors
12:00am
8-K
osou19hcfwzf
12 Nov 15
Inotek Pharmaceuticals Corporation Reports Third Quarter 2015
12:00am
8-K/A
944dvz9hzt5rad6
23 Oct 15
Departure of Directors or Certain Officers
12:00am
8-K
yqpm3 wm1ny
16 Oct 15
Inotek Pharmaceuticals Initiates Dosing of MATRx-1, the First Pivotal Phase 3 Clinical Trial of Trabodenoson, a Novel Treatment for Glaucoma
12:00am
8-K
bpzlf0cf4kl6tk1wdys7
13 Oct 15
Inotek Pharmaceuticals Appoints Gary M. Phillips, MD, MBA, to Board of Directors
12:00am
8-K
5jwxz8nojssn1re39y02
18 Aug 15
Inotek Pharmaceuticals Corporation Announces Closing of $79.2 Million
12:00am
8-K
02yoas1
17 Aug 15
Inotek Pharmaceuticals Corporation Announces Pricing of $68.9 Million Public Offering
12:00am
8-K
w46h0zbi
7 Aug 15
Inotek Pharmaceuticals Corporation Reports Second Quarter 2015 Financial Results and Operational Highlights
12:00am